Elevation Oncology (NASDAQ:ELEV) Lowered to Market Perform Rating by Citizens Jmp
Citizens Jmp cut shares of Elevation Oncology (NASDAQ:ELEV – Free Report) from an outperform rating to a market perform rating in a report issued on Friday morning, MarketBeat reports. A number of other equities analysts also recently issued reports on ELEV. Stephens reissued an “overweight” rating and issued a $5.00 price objective on shares of […]
Citizens Jmp cut shares of Elevation Oncology (NASDAQ:ELEV – Free Report) from an outperform rating to a market perform rating in a report issued on Friday morning, MarketBeat reports. A number of other equities analysts also recently issued reports on ELEV. Stephens reissued an “overweight” rating and issued a $5.00 price objective on shares of […]
